amgen Investors_2006_Annual Report
Beauty of cyclosporine
Adalimumab in combination with methotrexate
Treatment of Psoriasis
Otezla ® - apremilast Manufacturer: Celgene Corporation FDA Approval Date: 9/23/14.
Gazing into the Crystal Ball: How will Evolving Future Therapies Change how we Position Biologics for Use in IBD? William J. Sandborn, MD Professor & Chief,
Management of psoriasis with biological agents in clinical practice
1 Tazarotene Capsules in the Treatment of Psoriasis FDA Advisory Committee Meeting July 12, 2004 Patricia S. Walker MD, PhD Vice President, Skin Care Pharmaceuticals.
